Pulmatrix (NASDAQ:PULM – Get Free Report) and Kineta (NASDAQ:KA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Risk and Volatility Pulmatrix has a beta of 0.74, […]
StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a report issued on Friday. The firm issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock Up 0.4 % PULM traded up $0.01 on Friday, hitting $2.61. The company had a trading volume of 18,247 shares, compared to its average volume […]
Pulmatrix (NASDAQ:PULM – Get Free Report) and Kineta (NASDAQ:KA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings. Valuation & Earnings This table compares Pulmatrix and Kineta’s […]
Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report) was the target of a large decline in short interest during the month of June. As of June 30th, there was short interest totalling 5,600 shares, a decline of 47.2% from the June 15th total of 10,600 shares. Based on an average daily volume of 14,500 shares, the […]
Equities researchers at StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. Pulmatrix Stock Down 0.4 % PULM stock opened at $2.68 on Friday. Pulmatrix has a twelve month low of $2.60 and a twelve […]